Quadazocine

This classification denotes an opioid receptor agonist and opiate antagonist with the molecular formula C25H37NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, X9BMD58553 chemically known as (-)-(2r,6s,11s)-1-cyclopentyl-5-(1,2,3,4,5,6-hexahydro-8-hydroxy-3,6,11-trimethyl-2,6-methano-3-benzazocin-11-yl)-3-pentanone but generally known as quadazocine, which bears US NIH Compound Identifier 115077. European Medicines Agency schedules Quadazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10185MIG. The term QUADAZOCINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26). Most nations schedule quadazocine under HS 29333999 and SITC 51574. As of Q4 2014, QUADAZOCINE remains the US FDA Preferred Term for this commodity. Quadazocine bears US NLM identifiers UMLS ID C0139649 and NCI Concept Code C80570. SMILES: CC12CCN(C(C1(C)CCC(=O)CCC3CCCC3)CC4=C2C=C(C=C4)O)C.